Not applicableLooking for participantsNCT06963307What this trial is testingNovel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung CancerWho this might be right forLung Cancer, Non-Small Cell JaxBio Ltd 300
Not applicableLooking for participantsNCT06287814What this trial is testingFrench Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)Who this might be right forColorectal CancerStage III Colon CancerMinimal Residual Disease+1 more University Hospital, Montpellier 70
Not applicableLooking for participantsNCT07524114What this trial is testingStudy of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)Who this might be right forBreast CancerLung CancerMelanoma+7 more University Health Network, Toronto 7,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685What this trial is testingMolecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Ruijin Hospital 218
Not applicableStudy completedNCT03054883What this trial is testingObservational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose TherapyWho this might be right forMantle Cell Lymphoma Czech Lymphoma Study Group 73
Testing effectiveness (Phase 2)Looking for participantsNCT07392970What this trial is testingMotixafortide for MRD Sensitization in AMLWho this might be right forAcute Myeloid LeukemiaMeasurable Residual Disease Washington University School of Medicine 10
Testing effectiveness (Phase 2)Looking for participantsNCT07256210What this trial is testingFeasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Testing effectiveness (Phase 2)Looking for participantsNCT04991103What this trial is testingMinimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)Who this might be right forMultiple MyelomaAmyloidosis University of Alabama at Birmingham 40
Not applicableLooking for participantsNCT06149910What this trial is testingEvaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple MyelomaWho this might be right forMultiple MyelomaMultiple Myeloma Without Mention of Remission All4Cure 450
Not applicableLooking for participantsNCT05196087What this trial is testingNon-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)Who this might be right forBreast CancerMelanomaGastrointestinal Neuroendocrine Tumor University Health Network, Toronto 500
Not applicableLooking for participantsNCT07104058What this trial is testingA Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RDWho this might be right forIgG4-Related Diseases Luo Yaping 46
Testing effectiveness (Phase 2)Ended earlyNCT06333678What this trial is testingA Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 10
Not applicableActive Not RecruitingNCT06398743What this trial is testingFirst CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal CancerWho this might be right forColorectal Cancer Exact Sciences Corporation 416
Testing effectiveness (Phase 2)Looking for participantsNCT07191717What this trial is testingImlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more Jonsson Comprehensive Cancer Center 42
Early research (Phase 1)Ended earlyNCT04748848What this trial is testingA Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive TherapyWho this might be right forLeukemia, Myeloid Celgene 1
Testing effectiveness (Phase 2)Ended earlyNCT03537599What this trial is testingDaratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell TransplantWho this might be right forMinimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more Sumithira Vasu 4
Not applicableActive Not RecruitingNCT06663787What this trial is testingPersonalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 TreatmentWho this might be right forBreast Cancer, MetastaticHER2 + Breast Cancer Nagoya City University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02724163What this trial is testingInternational Randomised Phase III Clinical Trial in Children With Acute Myeloid LeukaemiaWho this might be right forAcute Myeloid Leukaemia University of Birmingham 700
Not applicableLooking for participantsNCT06211166What this trial is testingAssessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain ReactionWho this might be right forAcute LeukemiaMDSMDS/MPN+1 more Peking University People's Hospital 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07823322What this trial is testingEvaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and ChemotherapyWho this might be right forCRC (Colorectal Cancer) Incyte Corporation 40